FDA Inspection 1271731 — Carter BloodCare - Arlington
The FDA completed an inspection of Carter BloodCare - Arlington on May 15, 2025 in Arlington, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 15, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Arlington, TX (United States)